The primary end point , that is , favorable outcome evaluated by survival without major neurological damage ( Cerebral Performance Categories 1-2 ) at day 28 , was not significantly different between groups ( odds ratio , 1.41 ; 95 % confidence interval , 0.93-2 .16 ; P = 0.107 ) .